Global Colloids (Blood Plasma) Market Size, Manufacturers, Opportunities and Forecast to 2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
According to APO Research, The global Colloids (Blood Plasma) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Colloids (Blood Plasma), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloids (Blood Plasma).
The Colloids (Blood Plasma) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colloids (Blood Plasma) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloids (Blood Plasma) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colloids (Blood Plasma) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloids (Blood Plasma).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Colloids (Blood Plasma) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
According to APO Research, The global Colloids (Blood Plasma) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Colloids (Blood Plasma), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloids (Blood Plasma).
The Colloids (Blood Plasma) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colloids (Blood Plasma) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- CSL Behring
- Baxter
- Grifols
- Octapharma
- Kedrion
- Shanghai Raas
- CTBB
- Hualan Bio
- Rongsheng Pharmaceutical
- Boya Rongsheng
- B. Braun Medical
- Fresenius Kabi
- HOSPIRA
- Axa parenterals
- Fresenius Kabi (China)
- CR Double-Crane
- Kelun Group
- Shandong Qidu Pharmaceutical
- Shandong Hualu Pharmaceutical
- Minsheng Pharma
- Kanglepharm
- Natural Type Colloids (Blood Plasma)
- Synthetic Type Colloids (Blood Plasma)
- Extensive Burns
- Massive Blood or Plasma Loss
- Hypovolemic Shock
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloids (Blood Plasma) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colloids (Blood Plasma) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloids (Blood Plasma).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Colloids (Blood Plasma) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Colloids (Blood Plasma) Sales Estimates and Forecasts (2019-2030)
1.3 Colloids (Blood Plasma) Market by Type
1.3.1 Natural Type Colloids (Blood Plasma)
1.3.2 Synthetic Type Colloids (Blood Plasma)
1.4 Global Colloids (Blood Plasma) Market Size by Type
1.4.1 Global Colloids (Blood Plasma) Market Size Overview by Type (2019-2030)
1.4.2 Global Colloids (Blood Plasma) Historic Market Size Review by Type (2019-2024)
1.4.3 Global Colloids (Blood Plasma) Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
1.5.2 Europe Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Colloids (Blood Plasma) Industry Trends
2.2 Colloids (Blood Plasma) Industry Drivers
2.3 Colloids (Blood Plasma) Industry Opportunities and Challenges
2.4 Colloids (Blood Plasma) Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Colloids (Blood Plasma) Revenue (2019-2024)
3.2 Global Top Players by Colloids (Blood Plasma) Sales (2019-2024)
3.3 Global Top Players by Colloids (Blood Plasma) Price (2019-2024)
3.4 Global Colloids (Blood Plasma) Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Colloids (Blood Plasma) Key Company Manufacturing Sites & Headquarters
3.6 Global Colloids (Blood Plasma) Company, Product Type & Application
3.7 Global Colloids (Blood Plasma) Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Colloids (Blood Plasma) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Colloids (Blood Plasma) Players Market Share by Revenue in 2023
3.8.3 2023 Colloids (Blood Plasma) Tier 1, Tier 2, and Tier
4 COLLOIDS (BLOOD PLASMA) REGIONAL STATUS AND OUTLOOK
4.1 Global Colloids (Blood Plasma) Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Colloids (Blood Plasma) Historic Market Size by Region
4.2.1 Global Colloids (Blood Plasma) Sales in Volume by Region (2019-2024)
4.2.2 Global Colloids (Blood Plasma) Sales in Value by Region (2019-2024)
4.2.3 Global Colloids (Blood Plasma) Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Colloids (Blood Plasma) Forecasted Market Size by Region
4.3.1 Global Colloids (Blood Plasma) Sales in Volume by Region (2025-2030)
4.3.2 Global Colloids (Blood Plasma) Sales in Value by Region (2025-2030)
4.3.3 Global Colloids (Blood Plasma) Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 COLLOIDS (BLOOD PLASMA) BY APPLICATION
5.1 Colloids (Blood Plasma) Market by Application
5.1.1 Extensive Burns
5.1.2 Massive Blood or Plasma Loss
5.1.3 Hypovolemic Shock
5.1.4 Others
5.2 Global Colloids (Blood Plasma) Market Size by Application
5.2.1 Global Colloids (Blood Plasma) Market Size Overview by Application (2019-2030)
5.2.2 Global Colloids (Blood Plasma) Historic Market Size Review by Application (2019-2024)
5.2.3 Global Colloids (Blood Plasma) Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
5.3.2 Europe Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 CSL Behring
6.1.1 CSL Behring Comapny Information
6.1.2 CSL Behring Business Overview
6.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
6.1.5 CSL Behring Recent Developments
6.2 Baxter
6.2.1 Baxter Comapny Information
6.2.2 Baxter Business Overview
6.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
6.2.5 Baxter Recent Developments
6.3 Grifols
6.3.1 Grifols Comapny Information
6.3.2 Grifols Business Overview
6.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
6.3.5 Grifols Recent Developments
6.4 Octapharma
6.4.1 Octapharma Comapny Information
6.4.2 Octapharma Business Overview
6.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
6.4.5 Octapharma Recent Developments
6.5 Kedrion
6.5.1 Kedrion Comapny Information
6.5.2 Kedrion Business Overview
6.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
6.5.5 Kedrion Recent Developments
6.6 Shanghai Raas
6.6.1 Shanghai Raas Comapny Information
6.6.2 Shanghai Raas Business Overview
6.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
6.6.5 Shanghai Raas Recent Developments
6.7 CTBB
6.7.1 CTBB Comapny Information
6.7.2 CTBB Business Overview
6.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
6.7.5 CTBB Recent Developments
6.8 Hualan Bio
6.8.1 Hualan Bio Comapny Information
6.8.2 Hualan Bio Business Overview
6.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
6.8.5 Hualan Bio Recent Developments
6.9 Rongsheng Pharmaceutical
6.9.1 Rongsheng Pharmaceutical Comapny Information
6.9.2 Rongsheng Pharmaceutical Business Overview
6.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.9.5 Rongsheng Pharmaceutical Recent Developments
6.10 Boya Rongsheng
6.10.1 Boya Rongsheng Comapny Information
6.10.2 Boya Rongsheng Business Overview
6.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
6.10.5 Boya Rongsheng Recent Developments
6.11 B. Braun Medical
6.11.1 B. Braun Medical Comapny Information
6.11.2 B. Braun Medical Business Overview
6.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
6.11.5 B. Braun Medical Recent Developments
6.12 Fresenius Kabi
6.12.1 Fresenius Kabi Comapny Information
6.12.2 Fresenius Kabi Business Overview
6.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
6.12.5 Fresenius Kabi Recent Developments
6.13 HOSPIRA
6.13.1 HOSPIRA Comapny Information
6.13.2 HOSPIRA Business Overview
6.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
6.13.5 HOSPIRA Recent Developments
6.14 Axa parenterals
6.14.1 Axa parenterals Comapny Information
6.14.2 Axa parenterals Business Overview
6.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
6.14.5 Axa parenterals Recent Developments
6.15 Fresenius Kabi (China)
6.15.1 Fresenius Kabi (China) Comapny Information
6.15.2 Fresenius Kabi (China) Business Overview
6.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
6.15.5 Fresenius Kabi (China) Recent Developments
6.16 CR Double-Crane
6.16.1 CR Double-Crane Comapny Information
6.16.2 CR Double-Crane Business Overview
6.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
6.16.5 CR Double-Crane Recent Developments
6.17 Kelun Group
6.17.1 Kelun Group Comapny Information
6.17.2 Kelun Group Business Overview
6.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
6.17.5 Kelun Group Recent Developments
6.18 Shandong Qidu Pharmaceutical
6.18.1 Shandong Qidu Pharmaceutical Comapny Information
6.18.2 Shandong Qidu Pharmaceutical Business Overview
6.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.18.5 Shandong Qidu Pharmaceutical Recent Developments
6.19 Shandong Hualu Pharmaceutical
6.19.1 Shandong Hualu Pharmaceutical Comapny Information
6.19.2 Shandong Hualu Pharmaceutical Business Overview
6.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.19.5 Shandong Hualu Pharmaceutical Recent Developments
6.20 Minsheng Pharma
6.20.1 Minsheng Pharma Comapny Information
6.20.2 Minsheng Pharma Business Overview
6.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
6.20.5 Minsheng Pharma Recent Developments
6.21 Kanglepharm
6.21.1 Kanglepharm Comapny Information
6.21.2 Kanglepharm Business Overview
6.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
6.21.5 Kanglepharm Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Colloids (Blood Plasma) Sales by Country
7.1.1 North America Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Colloids (Blood Plasma) Sales by Country (2019-2024)
7.1.3 North America Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
7.2 North America Colloids (Blood Plasma) Market Size by Country
7.2.1 North America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Colloids (Blood Plasma) Market Size by Country (2019-2024)
7.2.3 North America Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Colloids (Blood Plasma) Sales by Country
8.1.1 Europe Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Colloids (Blood Plasma) Sales by Country (2019-2024)
8.1.3 Europe Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
8.2 Europe Colloids (Blood Plasma) Market Size by Country
8.2.1 Europe Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Colloids (Blood Plasma) Market Size by Country (2019-2024)
8.2.3 Europe Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Colloids (Blood Plasma) Sales by Country
9.1.1 Asia-Pacific Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Colloids (Blood Plasma) Sales by Country (2019-2024)
9.1.3 Asia-Pacific Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Colloids (Blood Plasma) Market Size by Country
9.2.1 Asia-Pacific Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Colloids (Blood Plasma) Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Colloids (Blood Plasma) Sales by Country
10.1.1 Latin America Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Colloids (Blood Plasma) Sales by Country (2019-2024)
10.1.3 Latin America Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
10.2 Latin America Colloids (Blood Plasma) Market Size by Country
10.2.1 Latin America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Colloids (Blood Plasma) Market Size by Country (2019-2024)
10.2.3 Latin America Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Colloids (Blood Plasma) Sales by Country
11.1.1 Middle East and Africa Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2019-2024)
11.1.3 Middle East and Africa Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Colloids (Blood Plasma) Market Size by Country
11.2.1 Middle East and Africa Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Colloids (Blood Plasma) Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Colloids (Blood Plasma) Value Chain Analysis
12.1.1 Colloids (Blood Plasma) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Colloids (Blood Plasma) Production Mode & Process
12.2 Colloids (Blood Plasma) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Colloids (Blood Plasma) Distributors
12.2.3 Colloids (Blood Plasma) Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Colloids (Blood Plasma) Sales Estimates and Forecasts (2019-2030)
1.3 Colloids (Blood Plasma) Market by Type
1.3.1 Natural Type Colloids (Blood Plasma)
1.3.2 Synthetic Type Colloids (Blood Plasma)
1.4 Global Colloids (Blood Plasma) Market Size by Type
1.4.1 Global Colloids (Blood Plasma) Market Size Overview by Type (2019-2030)
1.4.2 Global Colloids (Blood Plasma) Historic Market Size Review by Type (2019-2024)
1.4.3 Global Colloids (Blood Plasma) Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
1.5.2 Europe Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Colloids (Blood Plasma) Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Colloids (Blood Plasma) Industry Trends
2.2 Colloids (Blood Plasma) Industry Drivers
2.3 Colloids (Blood Plasma) Industry Opportunities and Challenges
2.4 Colloids (Blood Plasma) Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Colloids (Blood Plasma) Revenue (2019-2024)
3.2 Global Top Players by Colloids (Blood Plasma) Sales (2019-2024)
3.3 Global Top Players by Colloids (Blood Plasma) Price (2019-2024)
3.4 Global Colloids (Blood Plasma) Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Colloids (Blood Plasma) Key Company Manufacturing Sites & Headquarters
3.6 Global Colloids (Blood Plasma) Company, Product Type & Application
3.7 Global Colloids (Blood Plasma) Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Colloids (Blood Plasma) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Colloids (Blood Plasma) Players Market Share by Revenue in 2023
3.8.3 2023 Colloids (Blood Plasma) Tier 1, Tier 2, and Tier
4 COLLOIDS (BLOOD PLASMA) REGIONAL STATUS AND OUTLOOK
4.1 Global Colloids (Blood Plasma) Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Colloids (Blood Plasma) Historic Market Size by Region
4.2.1 Global Colloids (Blood Plasma) Sales in Volume by Region (2019-2024)
4.2.2 Global Colloids (Blood Plasma) Sales in Value by Region (2019-2024)
4.2.3 Global Colloids (Blood Plasma) Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Colloids (Blood Plasma) Forecasted Market Size by Region
4.3.1 Global Colloids (Blood Plasma) Sales in Volume by Region (2025-2030)
4.3.2 Global Colloids (Blood Plasma) Sales in Value by Region (2025-2030)
4.3.3 Global Colloids (Blood Plasma) Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 COLLOIDS (BLOOD PLASMA) BY APPLICATION
5.1 Colloids (Blood Plasma) Market by Application
5.1.1 Extensive Burns
5.1.2 Massive Blood or Plasma Loss
5.1.3 Hypovolemic Shock
5.1.4 Others
5.2 Global Colloids (Blood Plasma) Market Size by Application
5.2.1 Global Colloids (Blood Plasma) Market Size Overview by Application (2019-2030)
5.2.2 Global Colloids (Blood Plasma) Historic Market Size Review by Application (2019-2024)
5.2.3 Global Colloids (Blood Plasma) Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
5.3.2 Europe Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Colloids (Blood Plasma) Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 CSL Behring
6.1.1 CSL Behring Comapny Information
6.1.2 CSL Behring Business Overview
6.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
6.1.5 CSL Behring Recent Developments
6.2 Baxter
6.2.1 Baxter Comapny Information
6.2.2 Baxter Business Overview
6.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
6.2.5 Baxter Recent Developments
6.3 Grifols
6.3.1 Grifols Comapny Information
6.3.2 Grifols Business Overview
6.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
6.3.5 Grifols Recent Developments
6.4 Octapharma
6.4.1 Octapharma Comapny Information
6.4.2 Octapharma Business Overview
6.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
6.4.5 Octapharma Recent Developments
6.5 Kedrion
6.5.1 Kedrion Comapny Information
6.5.2 Kedrion Business Overview
6.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
6.5.5 Kedrion Recent Developments
6.6 Shanghai Raas
6.6.1 Shanghai Raas Comapny Information
6.6.2 Shanghai Raas Business Overview
6.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
6.6.5 Shanghai Raas Recent Developments
6.7 CTBB
6.7.1 CTBB Comapny Information
6.7.2 CTBB Business Overview
6.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
6.7.5 CTBB Recent Developments
6.8 Hualan Bio
6.8.1 Hualan Bio Comapny Information
6.8.2 Hualan Bio Business Overview
6.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
6.8.5 Hualan Bio Recent Developments
6.9 Rongsheng Pharmaceutical
6.9.1 Rongsheng Pharmaceutical Comapny Information
6.9.2 Rongsheng Pharmaceutical Business Overview
6.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.9.5 Rongsheng Pharmaceutical Recent Developments
6.10 Boya Rongsheng
6.10.1 Boya Rongsheng Comapny Information
6.10.2 Boya Rongsheng Business Overview
6.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
6.10.5 Boya Rongsheng Recent Developments
6.11 B. Braun Medical
6.11.1 B. Braun Medical Comapny Information
6.11.2 B. Braun Medical Business Overview
6.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
6.11.5 B. Braun Medical Recent Developments
6.12 Fresenius Kabi
6.12.1 Fresenius Kabi Comapny Information
6.12.2 Fresenius Kabi Business Overview
6.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
6.12.5 Fresenius Kabi Recent Developments
6.13 HOSPIRA
6.13.1 HOSPIRA Comapny Information
6.13.2 HOSPIRA Business Overview
6.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
6.13.5 HOSPIRA Recent Developments
6.14 Axa parenterals
6.14.1 Axa parenterals Comapny Information
6.14.2 Axa parenterals Business Overview
6.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
6.14.5 Axa parenterals Recent Developments
6.15 Fresenius Kabi (China)
6.15.1 Fresenius Kabi (China) Comapny Information
6.15.2 Fresenius Kabi (China) Business Overview
6.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
6.15.5 Fresenius Kabi (China) Recent Developments
6.16 CR Double-Crane
6.16.1 CR Double-Crane Comapny Information
6.16.2 CR Double-Crane Business Overview
6.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
6.16.5 CR Double-Crane Recent Developments
6.17 Kelun Group
6.17.1 Kelun Group Comapny Information
6.17.2 Kelun Group Business Overview
6.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
6.17.5 Kelun Group Recent Developments
6.18 Shandong Qidu Pharmaceutical
6.18.1 Shandong Qidu Pharmaceutical Comapny Information
6.18.2 Shandong Qidu Pharmaceutical Business Overview
6.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.18.5 Shandong Qidu Pharmaceutical Recent Developments
6.19 Shandong Hualu Pharmaceutical
6.19.1 Shandong Hualu Pharmaceutical Comapny Information
6.19.2 Shandong Hualu Pharmaceutical Business Overview
6.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.19.5 Shandong Hualu Pharmaceutical Recent Developments
6.20 Minsheng Pharma
6.20.1 Minsheng Pharma Comapny Information
6.20.2 Minsheng Pharma Business Overview
6.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
6.20.5 Minsheng Pharma Recent Developments
6.21 Kanglepharm
6.21.1 Kanglepharm Comapny Information
6.21.2 Kanglepharm Business Overview
6.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
6.21.5 Kanglepharm Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Colloids (Blood Plasma) Sales by Country
7.1.1 North America Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Colloids (Blood Plasma) Sales by Country (2019-2024)
7.1.3 North America Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
7.2 North America Colloids (Blood Plasma) Market Size by Country
7.2.1 North America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Colloids (Blood Plasma) Market Size by Country (2019-2024)
7.2.3 North America Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Colloids (Blood Plasma) Sales by Country
8.1.1 Europe Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Colloids (Blood Plasma) Sales by Country (2019-2024)
8.1.3 Europe Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
8.2 Europe Colloids (Blood Plasma) Market Size by Country
8.2.1 Europe Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Colloids (Blood Plasma) Market Size by Country (2019-2024)
8.2.3 Europe Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Colloids (Blood Plasma) Sales by Country
9.1.1 Asia-Pacific Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Colloids (Blood Plasma) Sales by Country (2019-2024)
9.1.3 Asia-Pacific Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Colloids (Blood Plasma) Market Size by Country
9.2.1 Asia-Pacific Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Colloids (Blood Plasma) Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Colloids (Blood Plasma) Sales by Country
10.1.1 Latin America Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Colloids (Blood Plasma) Sales by Country (2019-2024)
10.1.3 Latin America Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
10.2 Latin America Colloids (Blood Plasma) Market Size by Country
10.2.1 Latin America Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Colloids (Blood Plasma) Market Size by Country (2019-2024)
10.2.3 Latin America Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Colloids (Blood Plasma) Sales by Country
11.1.1 Middle East and Africa Colloids (Blood Plasma) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2019-2024)
11.1.3 Middle East and Africa Colloids (Blood Plasma) Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Colloids (Blood Plasma) Market Size by Country
11.2.1 Middle East and Africa Colloids (Blood Plasma) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Colloids (Blood Plasma) Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Colloids (Blood Plasma) Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Colloids (Blood Plasma) Value Chain Analysis
12.1.1 Colloids (Blood Plasma) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Colloids (Blood Plasma) Production Mode & Process
12.2 Colloids (Blood Plasma) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Colloids (Blood Plasma) Distributors
12.2.3 Colloids (Blood Plasma) Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
